Insilico Design  synthesis and biological evaluation of acridine derivatives for targeting breast cancer

dc.contributor.guide	R, Kalirajan
dc.coverage.spatial	Pharmacy
dc.creator.researcher	Pandiselvi, A
dc.date.accessioned	2024-06-12T04:12:56Z
dc.date.available	2024-06-12T04:12:56Z
dc.date.awarded	2024
dc.date.completed	2024
dc.date.registered	2017
dc.description.abstract	Available
dc.description.note	Summary 101-104p References 105-112 p
dc.format.accompanyingmaterial	CD
dc.format.dimensions	3
dc.format.extent	1-115p
dc.identifier.uri	http://hdl.handle.net/10603/570829
dc.language	English
dc.publisher.institution	Colleges of Pharmacy
dc.publisher.place	Mysore
dc.publisher.university	JSS Academy of Higher Education and Research
dc.relation	82
dc.rights	university
dc.source.university	University
dc.subject.keyword	Anti-cancer, Breast cancer, DMBA induced, cell lines, Acridine, OECD
dc.subject.keyword	Clinical Pre Clinical and Health
dc.subject.keyword	Pharmacology and Pharmacy
dc.subject.keyword	Pharmacology and Toxicology
dc.title	Insilico Design synthesis and biological evaluation of acridine derivatives for targeting breast cancer
dc.title.alternative
dc.type.degree	Ph.D.